Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia
Clinical trial NCT04578210 · COMPLETED
Trial details
- NCT number
- NCT04578210
- Sponsor
- Instituto de Investigación Hospital Universitario La Paz
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-04
- Primary completion
- 2022-01-13
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.